Your browser doesn't support javascript.
loading
Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-ß1/ERK pathways.
Elbaz, Eman M; Amin, Hebat Allah A; Kamel, Ahmed S; Ibrahim, Sherehan M; Helmy, Hebatullah S.
Afiliação
  • Elbaz EM; Biochemistry Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St., Cairo, 11562, Egypt. eman.el-baz@pharma.cu.edu.eg.
  • Amin HAA; Pathology Department, Faculty of Medicine, Helwan University, Cairo, Egypt.
  • Kamel AS; Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt. Ahmed.seifeldin@pharma.cu.edu.eg.
  • Ibrahim SM; Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.
  • Helmy HS; Biochemistry Department, Faculty of Pharmacy, Cairo University, Kasr El Aini St., Cairo, 11562, Egypt.
Inflammopharmacology ; 28(5): 1407-1420, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32785828
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Sulfetos / Compostos Alílicos / Fatores Imunológicos / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Sulfetos / Compostos Alílicos / Fatores Imunológicos / Anti-Inflamatórios Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2020 Tipo de documento: Article